These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16520399)

  • 21. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.
    Shahin Y; Khan JA; Samuel N; Chetter I
    Atherosclerosis; 2011 May; 216(1):7-16. PubMed ID: 21411098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effects of felodipine and cilazapril on exercise performance in patients with mild to moderate hypertension. A crossover study.
    Paterna S; Di Pasquale P; Parrinello G; Tuttolomondo A; Follone G; Cardinale A; Ortoleva A; Giambanco F; Abruzzese G; Colomba D; Bologna P; Fernández P; Giubilato A; Valdes L; Albano V; Licata G
    Drugs Exp Clin Res; 2000; 26(4):125-31. PubMed ID: 11109512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effect of antihypertensive therapy with calcium antagonist or angiotensin converting enzyme inhibitor on serum nitrite/nitrate levels in human essential hypertension.
    Takase H; Sugiyama M; Nakazawa A; Sato K; Ueda R; Dohi Y
    Arzneimittelforschung; 2000 Jun; 50(6):530-4. PubMed ID: 10918945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients.
    Tiryaki O; Usalan C; Buyukhatipoglu H
    Nephrology (Carlton); 2010 Mar; 15(2):211-5. PubMed ID: 20470281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension.
    Beltman FW; Heesen WF; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Lie KI; Meyboom-de Jong B
    Blood Press; 1998 May; 7(2):109-17. PubMed ID: 9657538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up.
    Eveson DJ; Robinson TG; Potter JF
    Am J Hypertens; 2007 Mar; 20(3):270-7. PubMed ID: 17324738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
    Omvik P; Lund-Johansen P
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):193-206. PubMed ID: 8395198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregation.
    Labinjoh C; Newby DE; Wilkinson IB; Megson IL; MacCallum H; Melville V; Boon NA; Webb DJ
    Clin Sci (Lond); 2001 Feb; 100(2):127-35. PubMed ID: 11171280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive effects of aggressive vasodilator treatment of well-treated essential hypertensive patients.
    Engholm M; Mulvany MJ; Eftekhari A; Mathiassen ON; Buus NH; Christensen KL
    J Hum Hypertens; 2016 Nov; 30(11):690-696. PubMed ID: 26961172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].
    Statsenko ME; Derevianchenko MV
    Ter Arkh; 2014; 86(8):90-3. PubMed ID: 25306751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men.
    Pretorius M; Luther JM; Murphey LJ; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2435-40. PubMed ID: 16166566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure.
    Asayama K; Ohkubo T; Metoki H; Obara T; Inoue R; Kikuya M; Thijs L; Staessen JA; Imai Y;
    Hypertens Res; 2012 Nov; 35(11):1102-10. PubMed ID: 22895063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between endothelial function and fibrinolysis in early hypertension.
    Tomiyama H; Kimura Y; Mitsuhashi H; Kinouchi T; Yoshida H; Kushiro T; Doba N
    Hypertension; 1998 Jan; 31(1 Pt 2):321-7. PubMed ID: 9453323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension Optimal Treatment (HOT) trial.
    Parving HH
    Lancet; 1998 Aug; 352(9127):574-5. PubMed ID: 9716085
    [No Abstract]   [Full Text] [Related]  

  • 38. Haemodynamic effects of an antihypertensive diuretic substance on the forearm circulation of patients with essential hypertension.
    Bouthier JA; Safar ME; Deschamps E; Tarrade T
    Drugs Exp Clin Res; 1988; 14(2-3):221-4. PubMed ID: 3416724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood pressure reduction and tissue-type plasminogen activator release.
    Brown NJ
    Hypertension; 2006 Apr; 47(4):648-9. PubMed ID: 16520404
    [No Abstract]   [Full Text] [Related]  

  • 40. Different effect of antihypertensive drugs on conduit artery endothelial function.
    Ghiadoni L; Magagna A; Versari D; Kardasz I; Huang Y; Taddei S; Salvetti A
    Hypertension; 2003 Jun; 41(6):1281-6. PubMed ID: 12719441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.